New HIV-1 drug approved

EU to get new drug for treating HIV-1 infection.
A new once-daily integrase single tablet treatment designed to tackle the HIV-1 infection has received a nod of approval from the Committee for Medicinal Products for Human Use (CHMP), which will mean the drug could soon be endorsed throughout Europe.
The product Stribild, which was submitted to the branch of the European Medicines Agency (EMA) earlier this year by its developer Gilead Sciences, will now be reviewed by the European Commission before finally being put on sale throughout the 27-nation international community.
John Martin PhD, chairman and chief executive of Gilead Sciences, said the once-a-day nature of Stribild means that it has a huge potential for treating people with no known resistance to the components that make up the drug.
"We are pleased with today’s positive opinion from the CHMP and anticipate receiving a final decision from the European Commission on our application for Stribild in the coming months," he concluded.
Related News
-
News How can pharma achieve ‘Net Zero’? Through driving change in pharma manufacturing
Through the entire product lifecycle – production, consumption and disposal – the pharma industry significantly impacts the environment. -
News Planning for supply chain resilience
Engagement-based strategy could increase resilience of pharma supply chain. -
News Strategies for managing an outsourcing partner
Robust oversight linked to increased efficiency and better communication with outsourcing partners. -
News Updated: CPHI North America 2022 Blog
Follow along for live updates from CPHI North America, taking place in Philadelphia, PA from May 17-19. -
News Greater standardisation needed for effective ESG reporting - Expert panel
Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. -
News MedPharm: Increased investment driving developments in topical drugs market
We caught up with MedPharm at CPHI North America to discuss opportunities in the topical and transdermal products space. -
News Pharmapack Awards 2022: Winners Revealed
The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. -
News What it means to be 'At the heart of Pharma'
Informa Markets colleagues explain the motivations behind CPHI’s rebrand.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance